Disseminated superficial porokeratosis secondary to immunosuppression induced by etanercept for extensive psoriasis

Archives of Dermatology

Volumn 146, Issue 10, 2010, Pages 1193-1194

  Stewart, Lucy ^a,b   Howat, Alec ^a   Coulson, Ian ^a  

^a BURNLEY GENERAL HOSPITAL   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; IMMUNOGLOBULIN G; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; CASE REPORT; DISSEMINATED SUPERFICIAL POROKERATOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; POROKERATOSIS; PRIORITY JOURNAL; PSORIASIS; REMISSION; SKIN BIOPSY; TREATMENT OUTCOME; CHEMICALLY INDUCED; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; POROKERATOSIS; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 77958189752     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.298     Document Type: Letter

References (5)

1. Jung JY, Yeon JH, Ryu HS, Youn SW, Park KC, Huh CH. Disseminated superficial porokeratosis developed by immunosuppression due to rheumatoid arthritis treatment. J Dermatol. 2009;36(8):466-467.
2. Neumann RA, Knobler RM, Metze D, Jurecka W. Disseminated superficial porokeratosis and immunosuppression. Br J Dermatol. 1988;119(3):375-380.
3. Bencini PL, Tarantino A, Grimalt R, Ponticelli C, Caputo R. Porokeratosis and immunosuppression. Br J Dermatol. 1995;132(1):74-78.
4. Tsambaos D, Spiliopoulos T. Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression. J Am Acad Dermatol. 1993;28(4):651-652.
5. Galindo MP, Bartlett BL, Gewirtzman A, Mendoza N, Tremaine AM, Tyring SK. Etanercept: an overview of its role in the treatment of psoriasis. Expert Opin Drug Metab Toxicol. 2008;4(3):305-310.